Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 101,382 shares at $20.21 ($2.0M) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($2.0M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.21 | 50,691 | $1.0M | 50.0% |
| 2 | $20.21 | 50,691 | $1.0M | 50.0% |
| Total | $20.21 avg | 101,382 | $2.0M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |